Impact Biomedical Inc. Files 2024 10-K

Ticker: IBO · Form: 10-K · Filed: Mar 28, 2025 · CIK: 1834105

Impact Biomedical Inc. 10-K Filing Summary
FieldDetail
CompanyImpact Biomedical Inc. (IBO)
Form Type10-K
Filed DateMar 28, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

IMPACT BIOMEDICAL INC. FILED ITS 2024 10-K. CHECK FINANCIALS.

AI Summary

Impact Biomedical Inc. filed its 2024 10-K on March 28, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, incorporated in Nevada and operating in the pharmaceutical preparations sector, is headquartered in Houston, Texas. The filing provides detailed financial statements and disclosures for the fiscal years 2024, 2023, and 2022.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Impact Biomedical Inc.'s financial health and operational performance for the fiscal year 2024, enabling informed investment decisions.

Risk Assessment

Risk Level: low — The filing is a standard annual report and does not contain immediate red flags or significant negative disclosures.

Key Numbers

  • 2024 — Fiscal Year End (Reporting period for the 10-K)
  • 2023 — Prior Fiscal Year (Comparative financial data)
  • 2022 — Previous Fiscal Year (Comparative financial data)

Key Players & Entities

  • Impact Biomedical Inc. (company) — Filer of the 10-K
  • 2024-12-31 (date) — Fiscal year end
  • 2025-03-28 (date) — Filing date
  • Houston, TX (location) — Company headquarters
  • Pharmaceutical Preparations (industry) — Company's SIC code

FAQ

What is the primary business of Impact Biomedical Inc.?

Impact Biomedical Inc. operates in the Pharmaceutical Preparations industry, as indicated by its SIC code [2834].

When did Impact Biomedical Inc. file its 2024 annual report?

Impact Biomedical Inc. filed its 10-K for the fiscal year ending December 31, 2024, on March 28, 2025.

Where is Impact Biomedical Inc. headquartered?

The company's business address is listed as 1400 Broadfield Blvd., Suite 130, Houston, TX 77084.

What is the state of incorporation for Impact Biomedical Inc.?

Impact Biomedical Inc. is incorporated in Nevada (NV).

What financial periods are covered in this 10-K filing?

This 10-K filing provides financial information for the fiscal years ending December 31, 2024, December 31, 2023, and December 31, 2022.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 28, 2025 regarding IMPACT BIOMEDICAL INC. (IBO).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.